Related Experiment Video
Updated: Sep 6, 2025
03:53
Growing a Cystic Fibrosis-Relevant Polymicrobial Biofilm to Probe Community Phenotypes
Published on: April 19, 2024
658
Impact of Lung Microbiota on COPD
Cristina Russo1, Valeria Colaianni1, Giuseppe Ielo2
1Section of Pathology, Department of Biomedical and Biotechnological Sciences, University of Catania, 95123 Catania, Italy.
Biomedicines
|June 24, 2022
Summary
Altered lung microbiota is linked to chronic obstructive pulmonary disease (COPD). Interventions targeting this microbial imbalance may offer new therapeutic strategies for managing COPD and reducing inflammation.
Area of Science:
- Microbiology
- Pulmonology
- Immunology
Background:
- The lung microbiota plays a crucial role in respiratory health.
- Alterations in microbiota composition are associated with chronic obstructive pulmonary disease (COPD).
- The precise role of lung microbiota in stable and exacerbated COPD remains unclear.
Purpose of the Study:
- To review the intricate relationship between lung microbiota, immune response, and inflammation in COPD.
- To highlight the feedback loop connecting microbiota dysfunction, immune imbalance, and lung damage in COPD.
- To encourage the development of novel therapeutic strategies for COPD prevention and management.
Main Methods:
- Literature review focusing on the interplay between microbiota, immunity, and lung disease.
- Analysis of existing research on microbial dysbiosis in COPD patients.
- Synthesis of evidence regarding the anti-inflammatory potential of lung microbiota.
Main Results:
- Inflammation in COPD is characterized by microbial dysbiosis and immune system imbalance.
- Lung microbiota dysfunction contributes to reduced lung activity and inflammation.
- Microbiota-targeted interventions show potential for ameliorating COPD.
Conclusions:
- The lung microbiota-immune system interaction is central to COPD pathogenesis.
- Modulating the lung microbiota may offer a promising therapeutic avenue for COPD.
- Further research into microbiota-based therapies is warranted for COPD management.
More Related Videos
Related Concept Videos
01:22Chronic Obstructive Pulmonary Disease
1.4K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.4K
01:26COPD: Management Using Bronchodilators and Corticosteroids
292
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
292
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
3.0K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
3.0K
01:20COPD: Pathogenesis and Clinical Features
501
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
501
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
2.9K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.9K
01:25Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
2.9K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
2.9K